Athena Bioscience, LLC adalengeza mapulani okhazikitsa malonda a Nexiclon XR, mapiritsi okhawo omwe amatulutsidwa kamodzi patsiku a clonidine omwe amawonetsedwa pochiza matenda oopsa. kukhazikitsidwa kwakhazikitsidwa pa Epulo 1 m'maiko onse 2021 aku US.
Pafupifupi, 50% yokha ya akuluakulu amatsatira mankhwala ochiritsira matenda2, ndipo ngati ali ndi kuthamanga kwa magazi (BP), kutsika kwa kutsika kumagwirizanitsidwa ndi kulamulira kwa BP koipitsitsa ndi zotsatira zake zoipa, kuphatikizapo stroke, myocardial infarction, kulephera kwa mtima, ndi imfa.3-5 Nexiclon XR imapereka chithandizo chamankhwala chofanana ndi cha antihypertensive cha clonidine yotulutsidwa mwamsanga mu piritsi yabwino, kamodzi patsiku.6
"Tikukhulupirira kuti kugwiritsa ntchito piritsi kamodzi patsiku kungathandize kuti odwala azitsatira kwambiri mankhwala," atero a Jeff Bryant, CEO wa Athena. "Kutsata bwino kuyenera kupereka chithandizo chabwino kwa omwe akudwala matenda oopsa."
"Kukhazikitsidwa kwa Nexiclon XR kukuwonetsa kuti Tris akupitilizabe kuchita bwino pakubweretsa mankhwala osiyanasiyana opangidwa ndiukadaulo pamsika," atero CEO wa Tris Ketan Mehta. "Potengera mbiri yawo yotsimikizika, ndife okondwa kuti Athena ndi mnzathu, akuyambitsa chida chofunikira chamtima ichi." Nexiclon imachokera ku ukadaulo wa Tris's LiquiXR® wopereka mankhwala, zomwe zapangitsa kuti pakhale zinthu zambiri zoyambira m'gulu loyamba.
ZOMWE MUNGACHITE PA NKHANIYI:
- Pafupifupi, 50% yokha ya akuluakulu amatsatira mankhwala a matenda aakulu2, ndipo ngati ali ndi kuthamanga kwa magazi (BP), kutsika kwa kutsika kumagwirizanitsidwa ndi kulamulira kwa BP koipitsitsa ndi zotsatira zake zoipa, kuphatikizapo stroke, myocardial infarction, kulephera kwa mtima, ndi imfa.
- "Tikukhulupirira kuti kupezeka kwa piritsi kamodzi patsiku kungathandize kuti odwala azitsatira kwambiri mankhwala,".
- Kukhazikitsidwa kwakhazikitsidwa mu Epulo 2022 mu 50 U.
